U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
Approval is based on CROWN trial, which showed a 72% reduction in risk of progression or death for treatment with
Read moreThe latest news from the pharmaceutical sector. Covering the latest breaking news, encompassing company news from leading pharmaceutical companies and related companies.
Approval is based on CROWN trial, which showed a 72% reduction in risk of progression or death for treatment with
Read moreEisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has decided to assent to and support
Read moreSanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France – March
Read moreTHOUSAND OAKS, Calif., March 3, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76
Read moreOsaka, Japan, and New York, March 3, 2021 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Ovid Therapeutics Inc. (NASDAQ:
Read moreFor media and investors only Issued: London UK Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today provided
Read more3 March 2021 07:00 GMT The US District Court for the Northern District of West Virginia has decided in favour
Read moreJohnson & Johnson Statement on Collaboration with Merck | Johnson & Johnson Skip to content Our Company Johnson & Johnson
Read moreTHOUSAND OAKS, Calif., March 2, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that data from a multicenter, randomized Phase 3
Read moreShareholders approve 24th consecutive dividend increase to CHF 3.00 (+1.7%) per share for 2020; representing a 3.8% yield1 and approximately
Read more2 March 2021 12:15 GMT Supply to 142 countries underway as part of the unprecedented effort to bring broad and
Read moreFor media and investors only Issued: London, UK Data presented will demonstrate the potential of new antiretroviral mechanisms of action
Read moreCells have a built-in search and delete function. The existence of such a system came as a surprise 30 years
Read moreMarch 2, 2021 Otsuka Pharmaceutical Co., Ltd. Nutraceuticals Otsuka Pharmaceutical Co., Ltd. (Otsuka) has announced the launch of SOYJOY Coffee
Read moreEisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co.,
Read moreThis announcement contains inside information 1 March 2021 21:01 GMT AstraZeneca and FibroGen, Inc. (FibroGen) today announced that the US
Read more“Planetary health is directly related to human health and if we don’t change, the human species will disappear.” This was
Read moreNEW BRUNSWICK, N.J., February 28, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers
Read more01 Mar 2021 | Darmstadt, Germany Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation
Read moreNEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food
Read moreTARRYTOWN, N.Y., Feb. 27, 2021 /PRNewswire/ — Single administration of novel antibody cocktail controlled patients’ allergic response to cat allergen,
Read moreVote based on totality of scientific evidence provided by the Company including safety and efficacy data NEW BRUNSWICK, N.J., February
Read moreSpecial approval from German Federal Institute for Drugs and Medical Devices (BfArM) enables home use of a SARS-CoV-2 Rapid Antigen
Read more26 February 2021 14:00 GMT Tezepelumab demonstrated superiority versus placebo across every primary and key secondary endpoint in NAVIGATOR Phase
Read more